Oxular

£15.5m Series A financing complete

V-Bio Ventures joins investment syndicate Completes oversubscribed £15.5 million Series A financing round Accelerates development of additional product candidates Investors include Imperial Innovations, Consort Medical plc, NeoMed, V-Bio Ventures and Hovione Scientia Ltd Tuesday, 19 July 2016 – Precision Ocular, the Oxford-based retinal therapeutics company, today announces that V-Bio Ventures joins the Company’s successful Series …

£15.5m Series A financing complete Read More »

Innovations leads £13.5m funding round in Precision Ocular

22 February 2016 – Imperial Innovations Group plc (AIM: IVO, ‘the Group’, ‘Innovations’) has led a £13.5 million investment round in Precision Ocular Ltd (Precision Ocular), a London-based retinal therapeutics company. Innovations has committed £6.9 million to the round alongside other investors, including Consort Medical plc, a leading global single source pharma services drug and …

Innovations leads £13.5m funding round in Precision Ocular Read More »

Scroll to Top